Keyword: Pfizer

News

Obama Medicare Rebate Plan Could Hurt Drug Companies

14.02.2013 - President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...

News

Amgen Biosimilar Push Takes Aim at Blockbusters

07.02.2013 - Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...

News

Buyers Eye Multibillion Deal for Brazilian Drugmaker

07.02.2013 - International drug companies are considering bidding for Ache Laboratorios Farmaceuticos, one of Brazil's biggest drugmakers, in a deal valuing it at several billion dollars...

News

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

01.02.2013 - Pfizer's animal health subsidiary Zoetis raised $2.2 billion in its public offering on Thursday, becoming the largest IPO from a U.S. company since Facebook. Madison, New Jersey...

News

AbbVie Forecasts Slower Humira Growth

31.01.2013 - AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories, forecast 2013 earnings in line with Wall Street forecasts but slowing sales growth for...

News

Pfizer Q4 Results Top Forecast

29.01.2013 - Pfizer on Tuesday reported better-than-expected fourth-quarter results, helped by rebounding sales in emerging markets, but the drugmaker forecast 2013 profit weaker than Wall...

News

China to Cut Prices of More than 400 Drugs from February

08.01.2013 - China will cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20% from February, in a move to make medicines, including some products from Pfizer...

News

Italy's Philogen Signs Drug License Deal with Pfizer

04.01.2013 - Italian biopharmaceutical company Philogen has signed a worldwide license agreement with drug firm Pfizer for the development of Dekavil, an experimental treatment for autoimmune...